Adults with asthma who became infected with the coronavirus that causes COVID-19 were at higher risk of developing severe illness compared with adults who did not have asthma, according to a new study.
You’re listening to a press conference from the Harvard T.H. Chan School of Public Health with Karestan Koenen, professor of psychiatric epidemiology at the … Continue reading “Coronavirus (COVID-19): Press Conference with Karestan Koenen, 06/10/20”
You’re listening to a press conference from the Harvard T.H. Chan School of Public Health with Yonatan Grad, the Melvin J. And Geraldine L. … Continue reading “Coronavirus (COVID-19): Press Conference with Yonatan Grad, 06/09/20”
You’re listening to a press conference from the Harvard T.H. Chan School of Public Health with Michael Mina, assistant professor of epidemiology and a … Continue reading “Coronavirus (COVID-19): Press Conference with Michael Mina, 06/08/20”
You’re listening to a press conference from the Harvard T.H. Chan School of Public Health with Michael Mina, assistant professor of epidemiology and a … Continue reading “Coronavirus (COVID-19): Press Conference with Michael Mina, 06/05/20”
Graduates of the Global Initiative for Neuropsychiatric Genetics Education in Research (GINGER) are poised to elevate neuropsychiatric genetics research across Africa.
Nancy Krieger, professor of social epidemiology at Harvard Chan School, discusses how longstanding structural racism has both fueled the unrest in the wake of George Floyd’s death and, at the same time, has made COVID-19 particularly lethal for people of color.
You’re listening to a press conference from the Harvard T.H. Chan School of Public Health with Barry Bloom, professor of immunology and infectious diseases … Continue reading “Coronavirus (COVID-19): Press Conference with Barry Bloom and Bill Hanage, 06/03/20”
Amid the coronavirus pandemic, Harvard Chan School students connected this spring with isolated local seniors at Roxbury Tenants of Harvard.
Three teams with ties to Harvard T.H. Chan School of Public Health—Vincere Health, Concerto Biosciences, and SanaRx—were among the finalists in the 2020 President’s Innovation Challenge presented by the Harvard Innovation Labs, and two were awarded prizes.
